Plus   Neg

Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off

After falling sharply early in the session, shares of Teva Pharmaceutical Industries Ltd. (TEVA) continue to see significant weakness in afternoon trading on Wednesday. Teva is currently down by 4.9 percent after moving higher for three straight sessions.

The pullback by Teva comes after a report from Reuters said pharmacy benefits manager Express Scripts Holding Co. (ESRX) will cover new migraine drugs from Eli Lilly & Co. (LLY) and Amgen Inc. (AMGN) but is excluding a rival medication made by Teva.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT